10x Genomics Inc (NAS:TXG)
$ 24.83 -0.18 (-0.72%) Market Cap: 2.97 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 76/100

10X Genomics Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 07:15PM GMT
Release Date Price: $127.72 (-0.05%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good afternoon, everybody. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company, 10x Genomics. Just a quick reminder, if you have questions, you can submit them through the website.

And with that, I'll turn it over to Serge.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thanks, Tycho. Next slide. Before we begin, I want to invite your attention to our safe harbor statement on Slide 2 and to visit our website for additional disclosures regarding any forward-looking statements that are made during the presentation today.

This is the century of biology. The progress in life sciences is in an exponential trajectory driven by advances in miniaturization, computation and compounding effects of the accumulation of biological knowledge. These advances will transform human health because they will allow us to develop cures based on the actual understanding of the underlying biological systems,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot